Ortho-Bromophenylpiperazine
Pharmaceutical compound
From Wikipedia, the free encyclopedia
ortho-Bromophenylpiperazine (oBPP), also known as 2-bromophenylpiperazine (2-BPP), is a monoamine releasing agent of the phenylpiperazine family.[1] It acts as a serotonin–norepinephrine–dopamine releasing agent (SNDRA), with EC50 values of 132 nM for serotonin, 33 nM for norepinephrine, and 250 nM for dopamine in rat brain synaptosomes.[1] The drug was first described in the scientific literature by 2012.[1]
Other namesoBPP; 2-Bromophenylpiperazine; 2-BPP; 2-Bromo-PP
| Clinical data | |
|---|---|
| Other names | oBPP; 2-Bromophenylpiperazine; 2-BPP; 2-Bromo-PP |
| Drug class | Serotonin–norepinephrine–dopamine releasing agent |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.199.072 |
| Chemical and physical data | |
| Formula | C10H13BrN2 |
| Molar mass | 241.132 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
See also
- ortho-Methylphenylpiperazine (oMPP)
- 2,3-Dichlorophenylpiperazine (2,3-DCPP)
- Benzylpiperazine (BZP)